Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Kerecis LLC, a pioneering company in the regenerative medicine sector, is headquartered in the United States. Founded in 2012, Kerecis has established itself as a leader in the development of fish skin-based products for wound care and tissue regeneration. The company operates primarily in North America and Europe, focusing on innovative solutions that harness the unique properties of fish skin to promote healing.
Kerecis's flagship products, including Kerecis Omega3 Wound and Kerecis Omega3 Graft, are distinguished by their ability to integrate with human tissue, offering a natural alternative to traditional grafts. With a commitment to advancing healthcare, Kerecis has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. The company continues to set benchmarks in the industry, driving forward the future of wound care and tissue repair.
+34 vs industry average
Kerecis LLC’s score of 74 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Kerecis LLC yet.
Kerecis LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family relationship with Coloplast A/S, from which it inherits climate commitments and initiatives.
Kerecis LLC's climate commitments are influenced by Coloplast A/S's sustainability strategies, which include participation in various climate initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These initiatives aim to establish science-based targets for reducing greenhouse gas emissions across their operations.
While Kerecis LLC has not set its own reduction targets or reported specific emissions figures, it aligns with the broader sustainability goals of its parent company, Coloplast A/S. This alignment suggests a commitment to addressing climate change and reducing carbon footprints in line with industry standards.
As Kerecis LLC continues to develop its sustainability practices, it is expected to adopt more specific targets and reporting measures in the future, reflecting the growing emphasis on corporate responsibility in environmental stewardship.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Kerecis LLC yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Kerecis LLC yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more